These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32192377)

  • 1. Modeling tick vaccines: a key tool to improve protection efficacy.
    de la Fuente J; Estrada-Peña A; Contreras M
    Expert Rev Vaccines; 2020 Mar; 19(3):217-225. PubMed ID: 32192377
    [No Abstract]   [Full Text] [Related]  

  • 2. High throughput discovery and characterization of tick and pathogen vaccine protective antigens using vaccinomics with intelligent Big Data analytic techniques.
    De La Fuente J; Villar M; Estrada-Peña A; Olivas JA
    Expert Rev Vaccines; 2018 Jul; 17(7):569-576. PubMed ID: 29953298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tick vaccines: current status and future directions.
    de la Fuente J; Contreras M
    Expert Rev Vaccines; 2015; 14(10):1367-76. PubMed ID: 26289976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the identification and characterization of protective antigens for recombinant vaccines against tick infestations.
    de la Fuente J; Kocan KM
    Expert Rev Vaccines; 2003 Aug; 2(4):583-93. PubMed ID: 14711342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of vaccine candidates against Hyalomma anatolicum-Vector of Crimean-Congo haemorrhagic fever virus.
    Manjunathachar HV; Kumar B; Saravanan BC; Choudhary S; Mohanty AK; Nagar G; Chigure G; Ravi Kumar GVPPS; de la Fuente J; Ghosh S
    Transbound Emerg Dis; 2019 Jan; 66(1):422-434. PubMed ID: 30300470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for new and improved vaccines against ticks and tick-borne diseases.
    de la Fuente J; Kopáček P; Lew-Tabor A; Maritz-Olivier C
    Parasite Immunol; 2016 Dec; 38(12):754-769. PubMed ID: 27203187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling ticks and tick-borne diseases…looking forward.
    de la Fuente J
    Ticks Tick Borne Dis; 2018 Jul; 9(5):1354-1357. PubMed ID: 29656834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tick vaccines and the transmission of tick-borne pathogens.
    de la Fuente J; Kocan KM; Blouin EF
    Vet Res Commun; 2007 Aug; 31 Suppl 1():85-90. PubMed ID: 17682852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccinomics, the new road to tick vaccines.
    de la Fuente J; Merino O
    Vaccine; 2013 Dec; 31(50):5923-9. PubMed ID: 24396872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular (ticks) and serological (humans) study of Crimean-Congo hemorrhagic fever virus in the Iberian Peninsula, 2013-2015.
    Palomar AM; Portillo A; Santibáñez S; García-Álvarez L; Muñoz-Sanz A; Márquez FJ; Romero L; Eiros JM; Oteo JA
    Enferm Infecc Microbiol Clin; 2017; 35(6):344-347. PubMed ID: 28291670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for development of vaccines for control of ixodid tick species.
    de la Fuente J; Kocan KM
    Parasite Immunol; 2006 Jul; 28(7):275-83. PubMed ID: 16842264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational biotechnology for the control of ticks and tick-borne diseases.
    de la Fuente J
    Ticks Tick Borne Dis; 2021 Sep; 12(5):101738. PubMed ID: 34023540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the tick-pathogen interface for novel control strategies.
    de la Fuente J; Kocan KM; Almazan C; Blouin EF
    Front Biosci; 2008 May; 13():6947-56. PubMed ID: 18508707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactomics and tick vaccine development: new directions for the control of tick-borne diseases.
    Artigas-Jerónimo S; De La Fuente J; Villar M
    Expert Rev Proteomics; 2018 Aug; 15(8):627-635. PubMed ID: 30067120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying proteomics to tick vaccine development: where are we?
    Villar M; Marina A; de la Fuente J
    Expert Rev Proteomics; 2017 Mar; 14(3):211-221. PubMed ID: 28099817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with proteins involved in tick-pathogen interactions reduces vector infestations and pathogen infection.
    Merino O; Antunes S; Mosqueda J; Moreno-Cid JA; Pérez de la Lastra JM; Rosario-Cruz R; Rodríguez S; Domingos A; de la Fuente J
    Vaccine; 2013 Dec; 31(49):5889-96. PubMed ID: 24084474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of infestations by Ixodes ricinus tick larvae in rabbits vaccinated with aquaporin recombinant antigens.
    Contreras M; de la Fuente J
    Vaccine; 2017 Mar; 35(9):1323-1328. PubMed ID: 28161419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
    Pavel STI; Yetiskin H; Kalkan A; Ozdarendeli A
    PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008834. PubMed ID: 33226988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tick and pathogen transmission blocking vaccines.
    van Oosterwijk JG
    Parasite Immunol; 2021 May; 43(5):e12831. PubMed ID: 33704804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposed and concealed antigens as vaccine targets for controlling ticks and tick-borne diseases.
    Nuttall PA; Trimnell AR; Kazimirova M; Labuda M
    Parasite Immunol; 2006 Apr; 28(4):155-63. PubMed ID: 16542317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.